Safety of prophylactic intracameral moxifloxacin use in cataract surgery

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 3, 2012, Pages 278-282

  Ekinci Koktekir, Bengu ^a   Aslan, Bekir Sitki ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b TOBB UNIVERSITY OF ECONOMICS AND TECHNOLOGY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN; POVIDONE IODINE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CATARACT EXTRACTION; CONTROLLED STUDY; CORNEA EDEMA; DRUG SAFETY; ENDOPHTHALMITIS; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; AZA COMPOUNDS; CATARACT; CATARACT EXTRACTION; CORNEA; ENDOPHTHALMITIS; FEMALE; HUMANS; INTRAOCULAR PRESSURE; MACULAR EDEMA; MALE; MIDDLE AGED; PHACOEMULSIFICATION; POST-EXPOSURE PROPHYLAXIS; QUINOLINES; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84862166537     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0132     Document Type: Article

References (19)

1. Han, D.P., Wisniewski, S.R., Wilson, L.A., et al. Spectrum and susceptibilities of microbiologic isolates in the endophthalmitis vitrectomy study. Am. J. Ophthalmol. 122:1-17, 1996. (Pubitemid 26230889)
2. Speaker, M.G., Milch, F.A., Shah, M.K., et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 98:639-649, 1991.
3. Isenberg, S.J., Apt, L., Yoshimori, R., et al. Efficiency of topical povidine-iodine during the first week after ophthalmic surgery. Am. J. Ophthalmol. 124:31-35, 1997. (Pubitemid 27298987)
4. Ciulla, T.A., Starr, M.B., and Masket, S. Bacterial endophthalmitis prophylaxis for cataract surgery; an evidence-based update. Ophthalmology 109:13-14, 2002.
5. Masket, S. Preventing, diagnosing and treating endophthalmitis (guest editorial). J. Cataract Refract. Surg. 24:725-726, 1998.
6. Gimbel, H.V., and Sun, R. Prophylactic intracameral vancomycin and CME (letter). Ophthalmology 107:1614-1615, 2000.
7. Seal, D.V., Barry, P., Gettinby, G., et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; case for a European multicenter study; the ESCRS Endophthalmitis Study Group. J. Cataract Refract. Surg. 32:396-406, 2006. (Pubitemid 44313821)
8. Barry, P., Seal, D.V., Gettinby, G., et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study; the ESCRS Endophthalmitis Study Group. J. Cataract Refract. Surg. 32:407-410, 2006. (Pubitemid 44313820)
9. Mamalis, N., Edelhauser, H.F., Dawson, D.G., et al. Toxic anterior segment syndrome. J. Cataract Refract. Surg. 32:324-333, 2006.
10. Kowalski, R.P., Romanovski, E.G., Mah, F.S., et al. Intracameral Vigamox (moxifloxacin 0.5%) is nontoxic and effective in preventing endophthalmitis in a rabbit model. Am. J. Ophthalmol. 140:497-504, 2005.
11. Stroman, D.W., Dacjs, J.J., Cupp, G.A., and Schlech, B.A. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%; a new topical fluoroquinolone. Surv. Ophthalmol. 50(suppl):16-31, 2005.
12. Espiritu, C.R.G., Carapas, V.L., and Bolinao, J.G. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. J. Cataract Refract. Surg. 33:62-68, 2007.
13. Javitt, J.C., Vitale, S., Canner, J.K., et al. National outcomes of cataract extraction; endophthalmitis following inpatient surgery. Arch. Ophthalmol. 109:1085-1089, 1991.
14. Javitt, J.C., Street, D.A., Tielsch, J.M., et al. National outcomes after cataract extraction: retinal detachment and endophthalmitis after outpatient surgery; the Cataract Patient Outcomes Research Team. Ophthalmology 101:100-105, 1994.
15. West, E.S., Behrens, A., McDonnell, P.J., et al. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population between 1994 and 2001. Ophthalmology 112:1388-1394, 2005. (Pubitemid 41074627)
16. Taban, M., Behrens, A., Newcomb, R.L., et al. Acute endophthalmitis following cataract surgery: a systemic review of the literature. Arch. Ophthalmol. 123:613-620, 2005. (Pubitemid 40695508)
17. Miller, D., Flynn, P.M., Scott, I.U., et al. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch. Ophthalmol. 124:479-483, 2006.
18. Moshirfar, M., Feiz, V., Vitale, A.T., et al. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones; a retrospective observational case series. Ophthalmology 114:686-691, 2007. (Pubitemid 46483686)
19. Sclech, B.A., and Alfonso, E. Overview of the potency of moxifloxacin ophthalmic solution 0.5% (Vigamox). Surv. Ophthalmol. 50(Suppl):S7-S15, 2005. (Pubitemid 41657595)